Volume : 13, Issue : 11, November – 2026

Title:

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF RIOCIGUAT BY USING DIFFERENT POLYMERS

Authors :

N Srija, I. Nagaraju, Dr. V. Anjaneyulu, G Vijaya Kumar

Abstract :

The present study was aimed at the formulation and evaluation of sustained release (SR) matrix tablets of Riociguat using different polymers to prolong drug release and enhance therapeutic efficacy. Riociguat, a soluble guanylate cyclase stimulator indicated for pulmonary hypertension, requires controlled drug delivery to maintain steady plasma concentrations over an extended period. Sustained release matrix tablets were prepared by direct compression method employing various polymers such as Sodium alginate, Chitosan, and HPMC K15M in different ratios to modulate the drug release profile.
A total of nine formulations (F1–F9) were developed and evaluated for pre-compression and post-compression parameters. The pre-compression parameters including angle of repose, bulk density, tapped density, Carr’s index, and Hausner’s ratio indicated good flow properties of the powder blend, all within Indian Pharmacopoeia (IP) limits. The post-compression parameters such as weight variation, hardness, thickness, friability, and drug content were found to be within acceptable IP limits, confirming the suitability of the formulation process.
In vitro dissolution studies were carried out for 12 hours to assess the drug release profile of all formulations. Among the nine formulations, F2 was considered the optimized formulation as it exhibited a sustained and controlled drug release of 99.58% over 12 hours. The release kinetics suggested that the drug release followed a diffusion-controlled mechanism with polymer matrix swelling contributing to sustained action.
The study concludes that sustained release matrix tablets of Riociguat can be successfully formulated using Sodium alginate, Chitosan, and HPMC K15M, and the optimized formulation (F2) demonstrated desirable physicochemical characteristics and extended drug release, making it a promising candidate for once-daily sustained release therapy.
Keywords: Riociguat sustained Release Tablets, Sodium alginate, Chitosan, and HPMC K15M

Cite This Article:

Please cite this article in press N Srija et al., Formulation And Evaluation Of Sustained Release Matrix Tablets Of Riociguat By Using Different Polymers.,. Indo Am. J. P. Sci, 2026; 13(11)..

REFERENCES:

1. John C, Morten C. The Science of Dosage Form Design, Aulton: Modified release peroral dosage forms, Churchill Livingstone, 2, 2002, 290-300.
2. Brahmankar D M, Jaiswal S B. Biopharmaceutics and Pharmacokinetics Pharmacokinetics, Vallabh Prakashan, Delhi, 2(1), 2009, 399-401.
3. Lee V H L. Controlled Drug Delivery Fundamentals and Applications: Influence of drug properties on design, Marcel Dekker, Inc. New York, 2nd edition, 1987, 16-25.
4. Wani MS et al. Controlled Release System-A Review, 6(1), 2008. 5. Ho W H, Lee H L V. Sustained Drug Delivery Fundamentals and Applications: Design and fabrication of oral controlled release drug delivery system, Marcel Dekker Inc, New York: 2nd edition, 1987, 373-420.
6. Janos B, Klara P, Odon P, Geza R J, Rok D, Stane S, Istvan E. Film coating as a method to enhance the preparation of tablets from dimenhydrinate crystals, Int. J. Pharm. 269(2), 2004, 393-401.
7. Lachaman L, Liberman H A, Kanig J L. The theory and practice of industrial pharmacy. Varghese publishing house, 3rd edition, 1987, 23-28.
8. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm Sci, 52(12), 1963, 1145-1149.
9. Venkataraman D S N, Chester A, Kliener L. An overview of controlled release system, Handbook of pharmaceutical controlled release technology, Marc dekker Inc, 2000, 1-30.
10. Jain N K. Controlled and novel drug delivery. CBS pub and distribution, 50(1), 1997, 1-25.
11. Mamidala R, Ramana V, Lingam M, Gannu R, Rao MY. Review article factors influencing the design and performance of oral sustained/controlled release dosage form, Int. journal of pharmaceutical science and nanotechnology. 2(3), 2009, 583.
12. Cristina M, Aranzazu Z, Jose ML. Review: Critical factors in the release of drugs from sustained release hydrophilic matrices, Int Journal of Research in Ayurveda and Pharmacy, 2(6), 2011, 1701.
13. Wise DL. Handbook of pharmaceutical controlled release technology. Marcel dekkerInc new York, 1, 2002, 432-460.
14. Jamzad S, Fassihi R. Development of controlled release low dose class II drug-glipizide, Int. J. Pharm, 312(1-2), 2006, 24-32.
15. Salsa T, Veiga F, Pina ME. Oral controlled release dosage form. Cellulose ether polymers in hydrophilic matrices. Drug Develop. & Ind. Pharm. 23(9), 1997, 929-938.
16. Sung KC, Nixon PR, Skoug JW. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets, Int. J. Pharm, 142(1), 1996, 53-60.
17. Basak S, Reddy J B, Mani L K. Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet, Indian J. Pharm. Sci, 68(5), 2006, 594-598.
18. Lapidus H, Lordi N G. Studies on controlled release formulations, Journal of Pharmaceutical sciences, 57(8), 1968, 1292-1301.
19. Kamboj S, Gupta G D. Matrix Tablets: An important tool for oral controlled release dosage forms, Pharmainfo.net, 7(6), 2009, 1-9.
20. Vyas S P, Khar R K. Controlled Drug Delivery: Concepts and Advances. Vallabh prakashan, 1st edition, 2002, 156-189